SCHEMBL3435260

SCHEMBL3435260

O=S(=O)(NS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.62

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA2 P00918 20/20 0.62
CA1 P00915 19/20 0.62
MMP1 P03956 5/20 0.62
MMP2 P08253 5/20 0.62
MMP9 P14780 5/20 0.62
MMP8 P22894 5/20 0.62
MMP13 P45452 5/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2516323 0.97 CA2 (0.60) CA2CA1MMP1MMP2MMP9
SCHEMBL2512376 0.97 CA2 (0.60) CA2CA1MMP1MMP2MMP9
SCHEMBL2511858 0.97 CA2 (0.60) CA2CA1MMP1MMP2MMP9
SCHEMBL899196 0.97 CA2 (0.65) CA2CA1MMP1MMP2MMP9
SCHEMBL7797690 0.95 CA2 (0.67) CA2CA1MMP1MMP2MMP9
SCHEMBL20473121 0.95 CA2 (0.67) CA2CA1MMP1MMP2MMP9
SCHEMBL20476642 0.95 CA2 (0.62) CA2CA1MMP1MMP2MMP9
SCHEMBL898868 0.95 CA2 (0.67) CA2CA1MMP1MMP2MMP9
SCHEMBL548088 0.95 CA2 (0.54) CA2CA1MMP1MMP2MMP9
SCHEMBL20473120 0.92 CA2 (0.64) CA2CA1MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240339661-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS ENEVATE CORP (US) 2024-10-10 US claimed
WO-2022093716-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS ENEVATE CORPORATION (US) 2022-05-05 WO claimed
US-20240339661-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS ENEVATE CORP (US) 2024-10-10 US disclosed
WO-2022093716-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS ENEVATE CORPORATION (US) 2022-05-05 WO disclosed
US-20220131193-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS ENEVATE CORPORATION 2022-04-28 US disclosed
EP-2578567-B1 PROCESS FOR PREPARATION OF FLUORINE-CONTAINING IMIDE COMPOUNDS MITSUBISHI MATERIALS CORP (JP) 2016-01-13 EP disclosed
US-8759578-B2 Method for manufacturing fluorine-containing imide compound MITSUBISHI MATERIALS CORPORATION (JP) 2014-06-24 US disclosed
US-20130137899-A1 PROCESS FOR PRODUCING FLUORINE-CONTAINING SULFONYLIMIDE COMPOUND MITSUBISHI MATERIALS ELECTRONIC CHEMICALS CO., LTD (JP) 2013-05-30 US disclosed
US-20130102506-A1 LUBRICANT BASE OIL AND LUBRICANT COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2013-04-25 US disclosed
EP-2578567-A1 PROCESS FOR PREPARATION OF FLUORINE-CONTAINING IMIDE COMPOUNDS Mitsubishi Materials Corporation (JP) 2013-04-10 EP disclosed
US-20130066110-A1 METHOD FOR MANUFACTURING FLUORINE-CONTAINING IMIDE COMPOUND MITSUBISHI MATERIALS CORPORATION (JP) 2013-03-14 US disclosed
US-20120094235-A1 ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN USING THE COMPOSITION FUJIFILM CORPORATION (JP) 2012-04-19 US disclosed
US-20080081292-A1 RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2008-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131193-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS HCN2, IDH2, KCNJ1 CA2 137/4885CA1 491/4885MMP1 3739/4885
US-20240339661-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS HCN2, IDH2, KCNJ1 CA2 137/4885CA1 491/4885MMP1 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.